Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 2
1983 6
1984 5
1985 5
1986 10
1987 13
1988 10
1989 13
1990 8
1991 6
1992 17
1993 15
1994 11
1995 11
1996 4
1997 5
1998 7
1999 5
2000 12
2001 5
2002 5
2003 3
2004 3
2005 12
2006 3
2007 2
2008 8
2009 6
2010 7
2011 13
2012 16
2013 10
2014 10
2015 12
2016 8
2017 6
2018 2
2019 5
2020 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, André M, Fournier M, Gaulard P, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA) investigators. Peyrade F, et al. Among authors: thyss a. Lancet Oncol. 2011 May;12(5):460-8. doi: 10.1016/S1470-2045(11)70069-9. Epub 2011 Apr 7. Lancet Oncol. 2011. PMID: 21482186 Clinical Trial.
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Castaigne S, Pautas C, Terré C, Raffoux E, Bordessoule D, Bastie JN, Legrand O, Thomas X, Turlure P, Reman O, de Revel T, Gastaud L, de Gunzburg N, Contentin N, Henry E, Marolleau JP, Aljijakli A, Rousselot P, Fenaux P, Preudhomme C, Chevret S, Dombret H; Acute Leukemia French Association. Castaigne S, et al. Lancet. 2012 Apr 21;379(9825):1508-16. doi: 10.1016/S0140-6736(12)60485-1. Epub 2012 Apr 5. Lancet. 2012. PMID: 22482940 Clinical Trial.
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
Attal M, Lauwers-Cances V, Marit G, Caillot D, Moreau P, Facon T, Stoppa AM, Hulin C, Benboubker L, Garderet L, Decaux O, Leyvraz S, Vekemans MC, Voillat L, Michallet M, Pegourie B, Dumontet C, Roussel M, Leleu X, Mathiot C, Payen C, Avet-Loiseau H, Harousseau JL; IFM Investigators. Attal M, et al. N Engl J Med. 2012 May 10;366(19):1782-91. doi: 10.1056/NEJMoa1114138. N Engl J Med. 2012. PMID: 22571202 Free article. Clinical Trial.
Treating metastatic sarcomas locally: a paradoxe, a rationale, an evidence?
Olivier T, Pop D, Chouiter Djebaili A, Falk AT, Iannessi A, Saada E, Nettekoven W, Blay JY, Baque P, Cupissol D, Thyss A, Thariat J. Olivier T, et al. Among authors: thyss a. Crit Rev Oncol Hematol. 2015 Jul;95(1):62-77. doi: 10.1016/j.critrevonc.2015.01.004. Epub 2015 Jan 13. Crit Rev Oncol Hematol. 2015. PMID: 25630662 Review.
[Role of radiotherapy in the management of non-Hodgkin lymphomas].
Gastaud L, Rossignol B, Peyrade F, Ré D, Thariat J, Thyss A, Doyen J. Gastaud L, et al. Among authors: thyss a. Cancer Radiother. 2016 May;20(3):236-47. doi: 10.1016/j.canrad.2016.01.011. Epub 2016 Apr 25. Cancer Radiother. 2016. PMID: 27133378 Review. French.
Hodgkin's Lymphoma in Older Patients: an Orphan Disease?
Thyss A, Saada E, Gastaud L, Peyrade F, Re D. Thyss A, et al. Mediterr J Hematol Infect Dis. 2014 Jul 1;6(1):e2014050. doi: 10.4084/MJHID.2014.050. eCollection 2014. Mediterr J Hematol Infect Dis. 2014. PMID: 25045458 Free PMC article. Review.
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO.
Blay JY, Penel N, Toulmonde M, Valentin T, Chaigneau L, Rios M, Saada-Bouzid E, Firmin N, Bertucci F, Marec-Berard P, Ray-Coquard I, Lervat C, Rolland F, Thyss A, Conroy T, Brahmi M, Dufresne A, Merrouche Y, Brunat-Mentigny M, Biron P, Bompas E, Perol D; French Sarcoma Group. Blay JY, et al. Among authors: thyss a. Eur J Cancer. 2024 Sep;208:114228. doi: 10.1016/j.ejca.2024.114228. Epub 2024 Jul 15. Eur J Cancer. 2024. PMID: 39018632 Free article. Clinical Trial.
285 results